Combination of docetaxel and cetuximab for penile cancer: A case report and literature review

Anti-Cancer Drugs

Volumn 23, Issue 5, 2012, Pages 573-577

  Rescigno, Pasquale ^a   Matano, Elide ^a   Raimondo, Lucia ^a   Mainolfi, Ciro ^a   Federico, Piera ^a   Buonerba, Carlo ^a   Di Trolio, Rossella ^a   D'Aniello, Carmine ^a   Damiano, Vincenzo ^a   Palmieri, Giovannella ^a   De Placido, Sabino ^a   Di Lorenzo, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

cetuximab; chemotherapy; metastatic penile cancer

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; K RAS PROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RELAPSE; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTINUOUS INFUSION; DRUG TOLERABILITY; FOLLOW UP; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; KIDNEY INJURY; LOADING DRUG DOSE; MAINTENANCE THERAPY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; PENIS CARCINOMA; PRIORITY JOURNAL; PROPHYLAXIS; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; DRUG ADMINISTRATION SCHEDULE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; PENILE NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TAXOIDS; TREATMENT OUTCOME;

EID: 84859641835     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328350ead7     Document Type: Article

References (14)

1. Guimaraes GC, Rocha RM, Zequi SC, Cunha IW, Soares SA. Epidemiology and treatment. Curr Oncol Rep 2011; 13:231-239.
2. Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, et al. EAU penile cancer guidelines 2009. Eur Urol 2010; 57:1002-1012.
3. Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992; 147:630-632.
4. Haas GP, Blumenstein BA, Gagliano RG, Russell CA, Rivkin SE, Culkin DJ, et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999; 161:1823-1825. (Pubitemid 29420741)
5. Pizzocaro G, Nicolai N, Milani A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 2009; 55:546-551.
6. Nicolai N, Necchi A, Piva L, Torelli T, Catanzaro M, Biasoni D, et al. A combination of cisplatin and 5-fluorouracil plus a taxane for advanced squamous-cell carcinoma (SCC) of the penis: a single institution series. American Society Clinical Oncology, GenitoUrinary Cancer Symposium 2010, abs n1 255.
7. Di Lorenzo G, Federico P, Buonerba C, Longo N, Carteni G, Autorino R, et al. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol 2011; 60:1280-1284.
8. Lavens N, Gupta R, Wood LA. EGFR overexpression in squamous cell carcinoma of the penis. Curr Oncol 2010; 17:4-6.
9. Necchi A, Nicolai N, Colecchia M, Catanzaro M, Torelli T, Piva L, et al. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 2011; 29:e650-e652.
10. Carthon BC, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis. American Society Clinical Oncology, GenitoUrinary Cancer Symposium 2010, abs n1 254.
11. Hussein AM, Benedetto P, Sridhar KS. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinoma. Cancer 1990; 65:433-438.
12. Theodore C, Skoneczna I, Bodrogi I, Leahy I, Kerst JM, Collette M, et al. A phase II multicentre study of irinotecan (CPT11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 2008; 19:1304-1307. (Pubitemid 351911962)
13. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med 2007; 357:1695-1704. (Pubitemid 350005151)
14. Pagliaro LC, Williams DL, Daliani D, William MB, Osai W, Kincaid M, et al. Neoadjuvant paclitaxel, ifosfamide and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 2010; 28:3851-3857.